Type your tag names separated by a space and hit enter


ACUTE MYELOID LEUKEMIA (AML) is a topic covered in the Harrison's Manual of Medicine.

To view the entire topic, please or purchase a subscription.

Harrison’s Manual of Medicine 19th edition provides 600+ internal medicine topics in a rapid-access format. Download Harrison’s App to iPhone, iPad, and Android smartphone and tablet. Explore these free sample topics:

Harrison’s Manual of Medicine - App + Web

-- The first section of this topic is shown below --

AML is a clonal malignancy of myeloid bone marrow precursors in which poorly differentiated cells accumulate in the bone marrow and circulation.

Signs and symptoms occur because of the absence of mature cells normally produced by the bone marrow, including granulocytes (susceptibility to infection) and platelets (susceptibility to bleeding). In addition, if large numbers of immature malignant myeloblasts circulate, they may invade organs and rarely produce dysfunction. There are distinct morphologic subtypes (Table 65-1) that have largely overlapping clinical features. Of note is the propensity of pts with acute promyelocytic leukemia (APL) (FAB M3) to develop bleeding and disseminated intravascular coagulation, especially during induction chemotherapy, because of the release of procoagulants from their cytoplasmic granules.

World Health Organization Classificationa
AML with recurrent genetic abnormalities
 AML with t(8;21)(q22;q22); RUNX1-RUNX1T1b
 AML with inv(16)(p13.1;1q22) or t(16;16)(p13.1;q22); CBFB-MYH11b
 Acute promyelocytic leukemia with t(15;17)(q22;q12); PML-RARAb
 AML with t(9;11)(p22;q23); MLLT3-MLL
 AML with t(6;9)(p23;q34); DEK-NUP214
 AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1
 AML (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1
Provisional entity: AML with mutated NPM1
Provisional entity: AML with mutated CEBPA
AML with myelodysplasia-related changes
Therapy-related myeloid neoplasms
AML not otherwise specified
 AML with minimal differentiation
 AML without maturation
 AML with maturation
 Acute myelomonocytic leukemia
 Acute monoblastic and monocytic leukemia
 Acute erythroid leukemia
 Acute megakaryoblastic leukemia
 Acute basophilic leukemia
 Acute panmyelosis with myelofibrosis
Myeloid sarcoma
Myeloid proliferations related to Down syndrome
 Transient abnormal myelopoiesis
 Myeloid leukemia associated with Down syndrome
Blastic plasmacytoid dendritic cell neoplasm
Acute leukemia of ambiguous lineage
 Acute undifferentiated leukemia
 Mixed phenotype acute leukemia with t(9;22)(q34;q11,20); BCR-ABL11
 Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged
 Mixed phenotype acute leukemia, B/myeloid, NOS
 Mixed phenotype acute leukemia, T/myeloid, NOS
Provisional entity: Natural killer (NK)-cell lymphoblastic leukemia/lymphoma
French-American-British (FAB) Classificationc
 MO: Minimally differentiated leukemia
 Ml: Myeloblastic leukemia without maturation
 M2: Myeloblastic leukemia with maturation
 M3: Hypergranular promyelocytic leukemia
 M4: Myelomonocytic leukemia
 M4Eo: Variant: Increase in abnormal marrow eosinophils
 M5: Monocytic leukemia
 M6: Erythroleukemia (DiGuglielmo’s disease)
 M7: Megakaryoblastic leukemia
aFrom SH Swerdlow et al (eds): World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press, 2008.
bDiagnosis is AML regardless of blast count.
cFrom JM Bennett et al: Ann Intern Med 103:620, 1985.
Abbreviation: AML, acute myeloid leukemia.

-- To view the remaining sections of this topic, please or purchase a subscription --


Loscalzo, Joseph, et al., editors. "ACUTE MYELOID LEUKEMIA (AML)." Harrison's Manual of Medicine, 19th ed., McGraw Hill Inc., 2017. harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623592/all/ACUTE_MYELOID_LEUKEMIA__AML_.
ACUTE MYELOID LEUKEMIA (AML). In: Loscalzo J, Jameson JL, Longo DL, et al, eds. Harrison's Manual of Medicine. 19th ed. McGraw Hill Inc.; 2017. https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623592/all/ACUTE_MYELOID_LEUKEMIA__AML_. Accessed April 18, 2019.
ACUTE MYELOID LEUKEMIA (AML). (2017). In Loscalzo, J., Jameson, J. L., Longo, D. L., Hauser, S. L., Fauci, A. S., & Kasper, D. L. (Eds.), Harrison's Manual of Medicine. Available from https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623592/all/ACUTE_MYELOID_LEUKEMIA__AML_
ACUTE MYELOID LEUKEMIA (AML) [Internet]. In: Loscalzo J, Jameson JL, Longo DL, Hauser SL, Fauci AS, Kasper DL, editors. Harrison's Manual of Medicine. McGraw Hill Inc.; 2017. [cited 2019 April 18]. Available from: https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623592/all/ACUTE_MYELOID_LEUKEMIA__AML_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - ACUTE MYELOID LEUKEMIA (AML) ID - 623592 ED - Loscalzo,Joseph, ED - Jameson,J Larry, ED - Longo,Dan L, ED - Hauser,Stephen L, ED - Fauci,Anthony S, ED - Kasper,Dennis L, BT - Harrison's Manual of Medicine UR - https://harrisons.unboundmedicine.com/harrisons/view/Harrisons-Manual-of-Medicine/623592/all/ACUTE_MYELOID_LEUKEMIA__AML_ PB - McGraw Hill Inc. ET - 19 DB - Harrison's Manual of Medicine DP - Unbound Medicine ER -